nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accountability for medical participation in torture
|
Rubenstein, Leonard |
|
|
395 |
10240 |
p. 1827 |
artikel |
2 |
Acute liver failure
|
Vento, Sandro |
|
|
395 |
10240 |
p. 1833 |
artikel |
3 |
Acute liver failure – Authors' reply
|
Stravitz, R Todd |
|
|
395 |
10240 |
p. 1833-1834 |
artikel |
4 |
Aspirin for Lynch syndrome: a legacy of prevention
|
Yurgelun, Matthew B |
|
|
395 |
10240 |
p. 1817-1818 |
artikel |
5 |
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF V600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
|
Gutzmer, Ralf |
|
|
395 |
10240 |
p. 1835-1844 |
artikel |
6 |
Atrial septal defect and haemodynamic consequences of continuous positive airway pressure treatment
|
Eerdekens, Rob |
|
|
395 |
10240 |
p. 1864 |
artikel |
7 |
A view from UK public health registrars on the challenges of COVID-19
|
Allen, Matilda |
|
|
395 |
10240 |
p. 1830 |
artikel |
8 |
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
|
Burn, John |
|
|
395 |
10240 |
p. 1855-1863 |
artikel |
9 |
Clinical endpoint adjudication
|
Meah, Mohammed N |
|
|
395 |
10240 |
p. 1878-1882 |
artikel |
10 |
COVID-19 testing delays and pathology services in the UK
|
Banatvala, Jangu |
|
|
395 |
10240 |
p. 1831 |
artikel |
11 |
COVID-19 vaccines for all?
|
Usher, Ann Danaiya |
|
|
395 |
10240 |
p. 1822-1823 |
artikel |
12 |
Department of Error
|
|
|
|
395 |
10240 |
p. 1834 |
artikel |
13 |
Department of Error
|
|
|
|
395 |
10240 |
p. 1834 |
artikel |
14 |
Excess mortality in men and women in Massachusetts during the COVID-19 pandemic
|
Krieger, Nancy |
|
|
395 |
10240 |
p. 1829 |
artikel |
15 |
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
|
The Lancet Editors, |
|
|
395 |
10240 |
p. e102 |
artikel |
16 |
Increasing tobacco sales under the anti-smoking policy in China
|
Luo, Hailong |
|
|
395 |
10240 |
p. 1834 |
artikel |
17 |
Jacob Plange-Rhule
|
Green, Andrew |
|
|
395 |
10240 |
p. 1828 |
artikel |
18 |
Major burns: debt recovery or ethics?
|
Arkoulis, Nikolaos |
|
|
395 |
10240 |
p. e103-e104 |
artikel |
19 |
Medicine and medical science: Black lives must matter more
|
The Lancet, |
|
|
395 |
10240 |
p. 1813 |
artikel |
20 |
Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis
|
Ladhani, Shamez N |
|
|
395 |
10240 |
p. 1865-1877 |
artikel |
21 |
Minimise, manage, and modify: the UK must create and use time
|
Rochford, Connor |
|
|
395 |
10240 |
p. 1829-1830 |
artikel |
22 |
NICE guideline for rectal cancer: already out of date
|
Glynne-Jones, Robert |
|
|
395 |
10240 |
p. e105-e106 |
artikel |
23 |
Offline: COVID-19—what we can expect to come
|
Horton, Richard |
|
|
395 |
10240 |
p. 1821 |
artikel |
24 |
Questioning statin therapy for older patients
|
Abramson, John |
|
|
395 |
10240 |
p. 1831-1832 |
artikel |
25 |
Questioning statin therapy for older patients – Authors' reply
|
Fulcher, Jordan |
|
|
395 |
10240 |
p. 1832-1833 |
artikel |
26 |
Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
|
Mehra, Mandeep R |
|
|
395 |
10240 |
p. 1820 |
artikel |
27 |
Revisiting the 1957 and 1968 influenza pandemics
|
Honigsbaum, Mark |
|
|
395 |
10240 |
p. 1824-1826 |
artikel |
28 |
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
|
Zhu, Feng-Cai |
|
|
395 |
10240 |
p. 1845-1854 |
artikel |
29 |
The starting line for COVID-19 vaccine development
|
Lee, Nelson |
|
|
395 |
10240 |
p. 1815-1816 |
artikel |
30 |
The WHO we want
|
Nay, Olivier |
|
|
395 |
10240 |
p. 1818-1820 |
artikel |
31 |
Triple therapy for BRAF V600-mutated melanoma
|
Ribas, Antoni |
|
|
395 |
10240 |
p. 1814-1815 |
artikel |